Annual ROE
-258.44%
-191.83%-287.99%
31 December 2023
Summary:
Dyne Therapeutics annual return on equity is currently -258.44%, with the most recent change of -191.83% (-287.99%) on 31 December 2023. During the last 3 years, it has fallen by -241.08% (-1388.71%). DYN annual ROE is now -362.08% below its all-time high of 98.61%, reached on 31 December 2018.DYN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-57.46%
+11.39%+16.54%
30 September 2024
Summary:
Dyne Therapeutics quarterly return on equity is currently -57.46%, with the most recent change of +11.39% (+16.54%) on 30 September 2024. Over the past year, it has increased by +40.11% (+41.11%). DYN quarterly ROE is now -171.68% below its all-time high of -21.15%, reached on 30 September 2020.DYN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -288.0% | +41.1% |
3 y3 years | -1388.7% | -92.1% |
5 y5 years | -362.1% | - |
DYN ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -1388.7% | at low | -92.1% | +57.9% |
5 y | 5 years | -362.1% | at low | -171.7% | +57.9% |
alltime | all time | -362.1% | at low | -171.7% | +57.9% |
Dyne Therapeutics ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -57.46%(-16.5%) |
June 2024 | - | -68.85%(-37.9%) |
Mar 2024 | - | -110.92%(-18.7%) |
Dec 2023 | -258.44%(+288.0%) | -136.35%(+39.7%) |
Sept 2023 | - | -97.57%(+22.5%) |
June 2023 | - | -79.63%(+16.2%) |
Mar 2023 | - | -68.55%(+14.7%) |
Dec 2022 | -66.61% | -59.74%(+2.4%) |
Sept 2022 | - | -58.34%(+12.5%) |
June 2022 | - | -51.86%(+27.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -40.70%(+16.8%) |
Dec 2021 | -40.55%(+133.6%) | -34.86%(+16.5%) |
Sept 2021 | - | -29.91%(+25.8%) |
June 2021 | - | -23.78%(+2.5%) |
Mar 2021 | - | -23.19%(+9.5%) |
Dec 2020 | -17.36%(-83.6%) | -21.18%(+0.1%) |
Sept 2020 | - | -21.15%(-44.9%) |
June 2020 | - | -38.41%(-71.9%) |
Mar 2020 | - | -136.51%(+70.0%) |
Dec 2019 | -105.86%(-207.4%) | -80.32% |
Dec 2018 | 98.61% | - |
FAQ
- What is Dyne Therapeutics annual return on equity?
- What is the all time high annual ROE for Dyne Therapeutics?
- What is Dyne Therapeutics annual ROE year-on-year change?
- What is Dyne Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly ROE year-on-year change?
What is Dyne Therapeutics annual return on equity?
The current annual ROE of DYN is -258.44%
What is the all time high annual ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high annual return on equity is 98.61%
What is Dyne Therapeutics annual ROE year-on-year change?
Over the past year, DYN annual return on equity has changed by -191.83% (-287.99%)
What is Dyne Therapeutics quarterly return on equity?
The current quarterly ROE of DYN is -57.46%
What is the all time high quarterly ROE for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly return on equity is -21.15%
What is Dyne Therapeutics quarterly ROE year-on-year change?
Over the past year, DYN quarterly return on equity has changed by +40.11% (+41.11%)